N-Hydroxyarginine as a Redox Activated Nitric Oxide Therapy
University of Surrey
School of Biosciences and Medicine
Research Group:
Crabtree and Campagnolo
Endothelial dysfunction is a unifying mechanism in diabetes, atherosclerosis and other chronic cardiovascular diseases. It is driven by oxidative stress and loss of nitric oxide (NO) bioavailability, particularly through oxidation of the essential eNOS cofactor tetrahydrobiopterin (BH4) to 7,8‑dihydrobiopterin (BH2). Read more
Supervisors: Dr MC Crabtree, Dr P Campagnolo
12 July 2026
PhD Research Project
Competition Funded PhD Project (UK Students Only)